Drug intelligence / Profile preview

autologous adipose-derived mesenchymal stem cells (DNA International Hospital)

Development stage
Unknown
Lead developer
DNA International Hospital
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Autologous adipose-derived mesenchymal stem cell (AD-MSC) therapy is a cell-based biologic developed by DNA International General Hospital in Vietnam. It is designed to treat inflammaging, a state of chronic, low-grade, sterile inflammation that occurs during aging and is linked to various age-related diseases. The treatment involves the isolation of mesenchymal stem cells from the patient's own adipose tissue, followed by expansion and intravenous re-infusion. The therapeutic goal is to modulate the immune environment, specifically by reducing proinflammatory cytokines and restoring cytokine balance, thereby addressing the underlying inflammatory drivers of conditions like diabetes, obesity, and dyslipidemia.

Other names
autologous adipose tissue-derived mesenchymal stem cell transplantationAD-MSC therapy

Beyond the preview

Go deeper on autologous adipose-derived mesenchymal stem cells (DNA International Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous adipose-derived mesenchymal stem cells (DNA International Hospital).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call